Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRNA
09:01pm, Saturday, 24'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 2
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA) and certain officers.
A Securities Fraud Case Has Been Filed Against Moderna Inc And The Schall Law Firm Encourages Investors To Take Part
11:00am, Saturday, 24'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "th
NEW YORK--(BUSINESS WIRE)---- $MRNA #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been fi
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit
07:41pm, Friday, 23'rd Aug 2024
NEW YORK , Aug. 23, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Moderna, Inc
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna Lawsuit – MRNA
04:30pm, Friday, 23'rd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs
12:15pm, Friday, 23'rd Aug 2024
On Thursday, the FDA cleared new versions of Pfizer's (PFE) and Moderna's (MRNA) COVID-19 vaccines that are designed to match COVID-19 strains currently circulating in the country.
Contact Levi & Korsinsky by October 8, 2024 Deadline to Join Class Action Against Moderna, Inc. (MRNA)
11:15am, Friday, 23'rd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Moderna Is Being Sued By The Schall Law Firm For Possibly Breaching Securities Law And Stockholders Are Invited To Participate
11:00am, Friday, 23'rd Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "th
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna, Inc. Lawsuit - MRNA
07:15am, Friday, 23'rd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
MRNA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Moderna, Inc. to Contact the Firm Today!
07:00am, Friday, 23'rd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc.
Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
07:00am, Friday, 23'rd Aug 2024
CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mRESVIA® (mRNA-1345), an mRNA resp
Lost Money on Moderna, Inc.(MRNA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
05:45am, Friday, 23'rd Aug 2024
NEW YORK , Aug. 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit. CLASS DEFINITION: T
